TissueScan, Sarcoma cDNA Array I

SKU
HSRT101
48 samples covering 8-normal,1-Stage IB, 4-I, 1-IIA, 2-IIB, 8-II, 1-IIIC, 7-III, 2-IVA, 8-IV, 6-N/R. Available in 2, 5, 10 identical plates.
  $1,060.00
In Stock*
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Sarcoma cDNA Array I
Clinical Info
Diagnosis Category Sarcoma Cancer
Tissue Soft tissue, Muscle, Bone, Cartilage
Shipping Ambient
Description 48 samples covering 8-normal,1-Stage IB, 4-I, 1-IIA, 2-IIB, 8-II, 1-IIIC, 7-III, 2-IVA, 8-IV, 6-N/R. Available in 2, 5, 10 identical plates.
Reviews
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

BCL-W has a fundamental role in B cell survival and lymphomagenesis
Adams, Kim, Mitra et al
J. Clin. Invest. (2017)
AI Summary: In this study, OriGene products were used to manipulate BCL-W expression: the BCL2L2 (BCL-W) shRNA lentiviral particles (TL309065V) enabled knockdown experiments, and the BCL2L2 (BCL-W) human cDNA ORF clone (RC200386) facilitated overexpression studies, thereby helping to elucidate BCL-W’s role in B cell survival and lymphoma development.
Snippet: Cite SaveSaving
Recurrent cis-SAGe chimeric RNA, D2HGDH-GAL3ST2, in prostate cancer
Qin, Song, Chang et al
Cancer Lett. (2016) 380 (1), 39-46 DOI: 10.1016/j.canlet.2016.06.013
Cited by 47
AI Summary: OriGene products, specifically the cDNA sets and the HPRT103 TissueScan array, were used in this study to validate the presence and expression of the D2HGDH-GAL3ST2 chimeric RNA in normal and prostate cancer tissue samples.
Snippet: All of the samples were de-identified. Two additional cDNA sets of 17 normal and 79 tumor samples were purchased from OriGene Technologies. RNA extraction, PCR, and qRT-PCR. ... C. RNA expression of D2HGDH-GAL3ST2 in HPRT103 TissueScan array from OriGene ... Cite SaveSaving
BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
Zhang, Ma, Jing et al
Theranostics (2016) 6 (2), 219-30 DOI: 10.7150/thno.13178
Cited by 101
AI Summary: OriGene products, specifically the BRD4 shRNA (OriGene, #TL313482) and FoxM1 shRNA (OriGene, #TL313482A), were used in this study to selectively knock down BRD4 and FoxM1 expression in ovarian cancer cell lines, helping to demonstrate the role of these proteins in the cellular response to BET bromodomain inhibition.
FigureFigureFigure
Glucocorticoids mediate induction of microRNA-708 to suppress ovarian cancer metastasis through targeting Rap1B
Lin, Yeh, Chuang et al
Nat Commun (2015) 6, 5917 DOI: 10.1038/ncomms6917
Cited by 112
AI Summary: OriGene's commercial cDNA tissue arrays were used in this study to analyze gene expression in ovarian tumor samples, contributing to the investigation of glucocorticoid-induced miR-708 and its role in suppressing ovarian cancer metastasis.
Snippet: Human samples Frozen or paraffin-embedded ovarian tumour samples were obtained from the Department of Pathology, Taipei Veterans General Hospital, under the approved IRB protocol. Informed written consent was obtained from all patients who participated in the study. Tumour samples were collected during debulking surgery and patient’s identity of pathological specimens remained anonymous. Detailed ...
MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer
Macneil, Jiao, McEachern et al
Cancer Res. (2013)
AI Summary: OriGene’s TissueScan cDNA arrays and patient-derived tumor tissues were used in this study to analyze MKK3 gene copy number and expression levels in breast cancer samples.
Snippet: (Rocky Hill, NJ). TissueScan cDNA arrays and quantitative PCR Quantitative PCR cDNA arrays were conducted using cDNA arrays (Origene, Cancer Survey ... patient-derived tumor tissues (Origene and study patients) were incubated in 10 mM citrate- ... Cite SaveSaving
Alpha-1-antitrypsin therapy ameliorates acute colitis and chronic murine ileitis
Collins, Aherne, Ehrentraut et al
Inflamm. Bowel Dis. (2013) 19 (9), 1964-73 DOI: 10.1097/MIB.0b013e31829292aa
AI Summary: In this study, OriGene products, specifically the human AAT (SERPINA1) expression plasmid and anti-SERPINA1 antibody, were used to investigate the role and therapeutic effects of alpha-1-antitrypsin in murine models of inflammatory bowel disease by enabling overexpression and detection of AAT in experimental assays.
Snippet: Close Window. Close Window. Enter your Email address: Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent.
Showing 1-6 of 8 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products